Healthcare Pulse Report
Pristine Gaze’s Healthcare Pulse Report delivers your vital signs for investing in Australia’s most resilient sector. Every second and fourth Tuesday, we provide expert analysis of healthcare stocks positioned to benefit from Australia’s aging population, $101 billion government health funding, and the sector’s defensive characteristics during market volatility.
Australia’s healthcare sector consistently outperforms with annuity-style income streams and long-term lease stability. With healthcare expenditure reaching 10.7% of GDP and ranking 6th globally for healthcare quality, this sector offers institutional-grade stability for serious investors.
Features
✅ Bi-Weekly Stock Recommendations – 3-5 healthcare stocks across pharmaceuticals, biotechnology, medical devices, and healthcare services
✅ Sector Analysis & Trends – Government policy impacts, regulatory changes, and demographic drivers
✅ Company Deep-Dives – Financial health assessment, competitive positioning, and growth catalysts
✅ Buy/Sell/Hold Ratings – Clear investment general recommendations with price targets and risk assessments
✅ Pipeline Analysis – Clinical trial updates, drug approvals, and product launch timelines
✅ Defensive LOI Building – Recession-proof healthcare investments for capital preservation
✅ ASX Healthcare Index Tracking – Monitor sector performance vs. broader market
✅ FREE Daily Digest – Stay updated with regulatory approvals and market developments – SAVE $200
Price
$1,200.00
Our subscription comes with 14 days cooling-off period, however, it only applies to new subscribers.
By providing your details and clicking on the button below, you agree to Pristine Gaze Pty. Ltd. Terms and Conditions and Privacy Policy. And you consent to receive marketing offers by email, text message or phone call from us or our agents until you opt out. Before you access our services,. I understand and agree that these calls may be made using an auto-dialer. please read the Financial Service Guide available here.
Our Stock Selection Process
Powered by Technology | Guided by Expertise
At Pristine Gaze, our stock recommendations are the result of a meticulously designed research process that combines advanced technology with deep market expertise. Using cutting-edge data analytics tools, we scan and evaluate the Australian stock market (ASX) to identify high-potential stocks across sectors, from emerging industries to established market leaders. Our proprietary algorithms sift through vast financial data, detecting hidden trends and opportunities. Our expert analysts then refine these insights, ensuring each stock pick balances short-term gains with long-term growth, offering data-driven, expert-reviewed recommendations & ASX stock analysis.
Past Recommendations
| TICKER | Buying Price | Selling Price | P/L% |
|---|---|---|---|
| IPX | 2.00 | 4.04 | 102% |
| CBA | 102.63 | 149.21 | 45.39% |
| PNV | 2.5 | 3.25 | 30% |
| LKE | 0.06 | 0.05 | 16.67% |
| BC8 | 0.35 | 0.59 | 68.57% |
| REA | 122.58 | 235.87 | 92.42% |
| BHP | 46.07 | 40.07 | 13.02% |
| QAN | 6.07 | 8.54 | 40.69% |
Not every company performs as expected. Past performance is not an indication of future returns. “Gain/Loss” reflects movement in difference in average buy price and sell price plus dividends as a percentage of average buy price, and does not take into account costs or taxation. The information herein is provided on a read-only basis to give readers a general understanding of investment concepts. It should not be misconstrued as a call to action or specific investment advice.
Frequently Asked Questions
What is the difference between each report?
Each report focuses on different investment strategies and release schedules. The Daily Digest provides daily updates, while other reports cover specific areas like penny stocks, growth stocks, or dividend stocks.
Is this suitable for beginners?
Yes! Our reports cater to both beginners and seasoned investors, with clear guidance and expert recommendations.
Do I need to renew my subscription manually?
Yes, each subscription covers 12 + 2 months and requires renewal at the end of the period.
How do I access the reports?
Reports are delivered directly to your inbox on the scheduled day, allowing easy access to up-to-date stock market insights.
